News

Latest news

Hide mandatory notifications of trade

Bionor Researchers to Present Data on Vacc-4x Phase IIB Trial at World Vaccine Congress, Washington, DC

[Washington, DC -- 12 April 2012] Researchers from Bionor Pharma have been invited to present data at the World Vaccine Congress, on 13 April 2012.

Chief Scientific Officer Maja Sommerfelt will present quality controlled data with more details on the findings issued in 1Q 2012 indicating a statistically significant drop in viral load for patients who were given therapeutic HIV vaccine candidate Vacc-4x compared to those given a placebo.

Link to view the press release:

Bionor Researchers to Present Data on Vacc-4x Phase IIB Trial at World Vaccine Congress